AVX-470, an Orally Delivered Anti-Tumour Necrosis Factor Antibody for Treatment of Active Ulcerative Colitis: Results of a First-in-Human TrialM. Scott Harris, Barbara S. Fox, Theadore Ptak et al.|Journal of Crohn s and Colitis|2016Cited by 75